Organization | University of Tuebingen

University of Tuebingen Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Tübingen Germany (1477)

Organization Overview

First Clinical Trial

1993

NCT00002544

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Alternative names

CCU Translational Immunology, University Hospital Tübingen, Germany | CCU Translational Immunology, University Hospital Tuebingen, | Centre for Ophthalmology, University of Tuebingen | Children`s Hospital, Tuebingen | Department of dermatology, university of tuebingen | Department of General Neurology, University of Tuebingen Medical School, Tuebingen, Germany | Department of Internal Medicine, Internal Medicine II; Oncology, haematology, clinical immunology, rheumatology and pneumology University Hospital Tuebingen | Department of Internal Medicine VI: Psychosomatic Medicine and Psychotherapy, University of Tuebingen | Department of Neurosurgery Tuebingen | Department of Otorhinolaryngology, University of Tubingen | Department of Psychology, University of Tuebingen, Germany | Department of Urology, University of Tuebingen | Dept. of Dermatology, University Hopsital Tuebingen, Germany | Dept. of Neonatology, Tuebingen University Hospital | Dept. of Psychiatry and Psychotherapy, Hospital Sigmaringen, University of Tuebingen | Dept. of Urology, University Hospital Tübingen, Germany | Diakonie Klinikum Stuttgart | Diakonieklinikum Stuttgart, Germany | Dr. Margarete Fischer Bosch Institute of Clinical Pharmacology and University of Tuebingen | Dr. Philipp Zanger, MD MSc DTM | Eberhard Karls University | Eberhard Karls University Tuebingen | Infectomed GbR Zentrum fuer medizinische Studien, Stuttgart | Insitut of Tropical Medicine, University of Tubingen | Institute for Clinical Epidemiology and applied Biometry, University Tuebingen | Institute of Tropical Medicine / Centre for Clinical Trials, Eberhard Karls University | Institute of Tropical Medicine, University of Tuebingen | Institute of Tropical Medicine, University of Tuebingen, Wilhelmstr. 27, Germany | Joachim Riethmueller, Dr. med. | KKE Translational Immunology, University Hospital Tübingen | Klinik für Kinder- und Jugendmedizin Tübingen | Klinikum der Landeshauptstadt Stuttgart gKAö | Klinikum Stuttgart | Kreiskliniken Reutlingen | Kreiskliniken Reutlingen GmbH | Marienhospital Stuttgart | Medical Center II, University of Tuebingen, Germany | Medical Center University Hospital of Tuebingen | Medical Center University Hospital Tuebingen | Medical Center University of Tuebingen | Method Center, University of Tuebingen, Germany | PD Dr. Derek Zieker | Principal Investigator: Univ. Hospital Tuebingen, Dept. of Clinical Pharmacology | Prof. Dr. Katrin Giel | Robert Bosch Gesellschaft für Medizinische Forschung mbH | Robert-Bosch-Hospital, Stuttgart, Germany | Robert Bosch-Krankenhaus Stuttgart | Robert Bosch Krankenhaus, Stuttgart, Germany | Robert Bosch Medical Center | South West German Cancer Center, Medical Center II, University of Tuebingen | Tubingen | Tuebingen Clinical Hospital | Tuebingen University | Tuebingen University Hospital | Universitats Kinderklinik Tubingen | Universitats Kinderklinik Tubingen, Germany | Universität Tübingen | University-Children's Hospital TÃ¼bingen | University Children’s Hospital Tuebingen | University Children's Hospital Tuebingen / University Hospital Zurich, Department of Neonatology | University Department of General, Visceral and TransplantSurgery Tuebingen | University Hospital, Eberhard Karls University Tuebingen, Germany | University Hospital of TÃ¼bingen | University Hospital of Tübingen | University Hospital of Tuebingen | University-Hospital of Tuebingen, Department of General Neurology | University Hospital of Tuebingen, Germany | University Hospital TÃ¼bingen | University hospital Tübingen | University Hospital Tübingen | University Hospital Tuebingen | University Hospital Tuebingen, Center for Ophthalmology | University Hospital Tuebingen, Department of Neurosurgery | University Hospital Tuebingen, Department of oncology, hematology, rheumatology | University Hospital Tuebingen (Germany) | University Hospital Tuebingen, Germany | University Hospital Tuebingen, Germany; Dept. for Pediatric Gastroenterology and Hepatology | University Hospital Tuebingen (PI until 30Nov2004) | University of Tuebingen, Department of dermatology | University of Tuebingen, Department of Dermatology | University of Tuebingen, Dept. of Immunology | University of Tuebingen, Dept. of Medicine 2 | University of Tuebingen, Germany | University of Tuebingen Medical Center | University of Tuebingen, Paediatric Department | University Tuebingen | University Women's Hospital Tübingen | Universtitätsklinikum Tübingen | Zentrum fur Humangenetik Tuebingen | Zentrum für klinische Studien der UNiversitätsklinik Tübingen

University of Tuebingen Report issue

Drugs in Phase 4 Trials (27)

Drugs in Phase 3 Trials (77)

Drugs in Phase 2 Trials (84)

Drugs in Phase 1 Trials (38)

Drugs in Other Trials (46)

Experimental Indications (Clinical Trials, Phases 1-4)

Overview